|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q2 FY2023
As of May 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Royalty receivable | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Due from sponsor | ||||||||||||||||||||
| Due from related party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total due from related party | ||||||||||||||||||||
| Investments held in the Trust Account - current | ||||||||||||||||||||
| Other receivable | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Employee advance | ||||||||||||||||||||
| Franchise tax receivable | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Investments held in Trust Account | ||||||||||||||||||||
| Investments held in the Trust Account | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ DEFICIT | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Accrued liabilities payable to related party | ||||||||||||||||||||
| Accrued interest payable to related party | ||||||||||||||||||||
| Excise tax payable | ||||||||||||||||||||
| Financing payable | ||||||||||||||||||||
| Convertible notes payable | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Total convertible notes payable | ||||||||||||||||||||
| Note payable - related party, net of discount | ||||||||||||||||||||
| Earnout shares and sponsor earnout shares liability | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total earnout shares and sponsor earnout shares liability | ||||||||||||||||||||
| Due to investor | ||||||||||||||||||||
| Due to investor, net of debt discount | ||||||||||||||||||||
| Due to Shareholders | ||||||||||||||||||||
| Trust Account | ||||||||||||||||||||
| Shareholders | ||||||||||||||||||||
| Common Class A | ||||||||||||||||||||
| Total due to Shareholders | ||||||||||||||||||||
| Loan payable | ||||||||||||||||||||
| Franchise tax payable | ||||||||||||||||||||
| Income tax payable | ||||||||||||||||||||
| Derivative liability | ||||||||||||||||||||
| Warrant liability | ||||||||||||||||||||
| Common Class A | ||||||||||||||||||||
| Total warrant liability | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Convertible note – related party | ||||||||||||||||||||
| Deferred tax liability | ||||||||||||||||||||
| Deferred underwriting commissions in connection with the Initial Public Offering | ||||||||||||||||||||
| Derivative liabilities | ||||||||||||||||||||
| Convertible notes payable, net of discount, non-current | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Series C preferred stock, $0.001 par value, 8,500,000 shares authorized, 0 and 4,300,000 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Common Class A | ||||||||||||||||||||
| Total series C preferred stock, $0.001 par value, 8,500,000 shares authorized, 0 and 4,300,000 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Stockholders’ deficit | ||||||||||||||||||||
| Class A common stock, $0.0001 par value, 228,500,000 shares authorized, 4,933,091 and 1,064,255 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Common Class A | ||||||||||||||||||||
| Class B Common Stock | ||||||||||||||||||||
| Total class A common stock, $0.0001 par value, 228,500,000 shares authorized, 4,933,091 and 1,064,255 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ deficit | ||||||||||||||||||||
| Total liabilities, mezzanine equity and stockholders’ deficit | ||||||||||||||||||||
Loading...